An open, controlled, comparative clinical study to assess the efficacy and safety of Lekhan Basti and Navak Guggul in the management of Sthaulya (Obesity) with special regard to biochemical and genetic marker

TN Medical College BYL Nair Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. BMI: Between 28-32.9 / Grade I obesity
•2. Waist-Hip Ratio greater than the normal reference range as per WHO (Men > 0.90 and Women > 0.85)

•1.Patients with Grade II/Grade III obesity (BMI score between 33 to 38 or >38)
•2.Patients with past history of major cardiac conditions like acute coronary syndrome, Myocardial Infarction, cardiac arrhythmias and/or cardiac failure in the last 6 months
•3.Patients with severe &/or uncontrolled medical conditions like Diabetes mellitus (FBS > 200mg/dl) and hypertension (BP >160/100 mm Hg), endocrine disorders (Hyperthyroidism, hypothyroidism, Cushingâ??s syndrome), malignancies and/or any other clinically significant medical condition, which the investigator believes, will contraindicate his/her inclusion in the study.
•4.Patients with history of Immuno-compromised status (HIV, Hepatitis B & C etc.)
•5.Patients with any ano-rectal conditions like bleeding piles, fistula, fissure etc.
•6.Those receiving any other concomitant drugs that could confound the efficacy evaluation.
•7.Pregnant and/or lactating women
•8.Alcoholics and/or drug abusers.
•9.Any other condition which the Study Investigators think may jeopardize the study

发起方

TN Medical College BYL Nair Hospital